Extruded filaments derived 3D printed medicated skin patch to mitigate destructive pulmonary tuberculosis: design to delivery

References

• Sasikumar K, Ghosh AR, Dusthackeer A. Antimycobacterial potentials of quercetin and rutin against mycobacterium tuberculosis H37Rv. 3 Biotech. 2018;8(10):427.
   PubMedGoogle Scholar
• Butov D, Zaitseva S, Butova T, et al. Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy. Int J Mycobacteriol. 2016;5(4):446–453.
   PubMed Web of Science ®Google Scholar
• Butov DO, Zaitseva SI, Pitenko MM, et al. Morphological changes in experimental tuberculosis resulting from treatment with quercetin and polyvinylpyrrolidone. Int J Mycobacteriol. 2015;4(4):296–301.
   PubMed Web of Science ®Google Scholar
• Nishimuro H, Ohnishi H, Sato M, et al. Estimated daily intake and seasonal food sources of quercetin in Japan. Nutrients. 2015;7(4):2345–2358.
   PubMed Web of Science ®Google Scholar
• Linkevičiūtė A, Misiūnas A, Naujalis E, et al. Preparation and characterization of quercetin-loaded lipid liquid crystalline systems. Colloids Surf B Biointerfaces. 2015;128:296–303.
   PubMed Web of Science ®Google Scholar
• Dall’Acqua S, Miolo G, Innocenti G, et al. The photodegradation of quercetin: relation to oxidation. Molecules. 2012;17(8):8898–8907.
   PubMed Web of Science ®Google Scholar
• Masri M, Booth A, DeEds F. The metabolism and acid degradation of quercetin. Arch Biochem. 1959;85:284–286.
   PubMed Web of Science ®Google Scholar
• Shi X, Fan N, Zhang G, et al. Quercetin amorphous solid dispersions prepared by hot melt extrusion with enhanced solubility and intestinal absorption. Pharm Dev Technol. 2020;25(4):472–481.
   PubMed Web of Science ®Google Scholar
• Khor CM, Ng WK, Kanaujia P, et al. Hot-melt extrusion microencapsulation of quercetin for taste-masking. J Microencapsul. 2017;34(1):29–37.
   PubMed Web of Science ®Google Scholar
• Li B, Konecke S, Harich K, et al. Solid dispersion of quercetin in cellulose derivative matrices influences both solubility and stability. Carbohydr Polym. 2013;92(2):2033–2040.
   PubMed Web of Science ®Google Scholar
• de Mello Costa AR, Marquiafável FS, de Oliveira Lima Leite Vaz MM, et al. Quercetin-PVP K25 solid dispersions: preparation, thermal characterization and antioxidant activity. J Therm Anal Calorim. 2011;104(1):273–278.
   Web of Science ®Google Scholar
• Shao Y, Yu H, Yang Y, et al. A solid dispersion of quercetin shows enhanced Nrf2 activation and protective effects against oxidative injury in a mouse model of dry age-related macular degeneration. Oxid Med Cell Longev. 2019;2019:1479571.
   PubMed Web of Science ®Google Scholar
• Li Y-L, Yang Y, Bai T-C, et al. Heat capacity for the binary system of quercetin and poly (vinylpyrrolidone) K30. J Chem Eng Data. 2010;55(12):5856–5861.
   Web of Science ®Google Scholar
• Zhu J, Yang Z, Chen X, et al. Preparation and physicochemical characterization of solid dispersion of quercetin and polyvinylpyrrolidone. J Chin Pharm Sci. 2007;16(1):51.
   Google Scholar
• Repka MA, Majumdar S, Kumar Battu S, et al. Applications of hot-melt extrusion for drug delivery. Expert Opin Drug Deliv. 2008;5(12):1357–1376.
   PubMed Web of Science ®Google Scholar
• Economidou SN, Lamprou DA, Douroumis D. 3D printing applications for transdermal drug delivery. Int J Pharm. 2018;544(2):415–424.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Roy S, Nath Bhaumik K, et al. Comparative study of oral lipid nanoparticle formulations (LNFs) for chemical stabilization of antitubercular drugs: physicochemical and cellular evaluation. Artif Cells Nanomed Biotechnol. 2018;46(sup1):540–558.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Roy S, Bhaumik KN, et al. Mechanisms of the effectiveness of lipid nanoparticle formulations loaded with anti-tubercular drugs combinations toward overcoming drug bioavailability in tuberculosis. J Drug Target. 2020;28(1):55–69.
   PubMed Web of Science ®Google Scholar
• Kallakunta VR, Sarabu S, Bandari S, et al. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I. Expert Opin Drug Deliv. 2019;16(5):539–550.
   PubMed Web of Science ®Google Scholar
• Chaudhari VS, Borkar RM, Murty US, et al. Analytical method development and validation of reverse-phase high-performance liquid chromatography (RP-HPLC) method for simultaneous quantifications of quercetin and piperine in dual-drug loaded nanostructured lipid carriers. J Pharm Biomed Anal. 2020;186:113325.
   PubMed Web of Science ®Google Scholar
• Trenfield SJ, Awad A, Madla CM, et al. Shaping the future: recent advances of 3D printing in drug delivery and healthcare. Expert Opin Drug Deliv. 2019;16(10):1081–1094.
   PubMed Web of Science ®Google Scholar
• Long J, Gholizadeh H, Lu J, et al. Application of fused deposition modelling (FDM) method of 3D printing in drug delivery. Curr Pharm Des. 2017;23(3):433–439.
   PubMed Web of Science ®Google Scholar
• Bharkatiya M, Nema R, Bhatnagar M. Designing and characterization of drug free patches for transdermal application. Int J Pharm Sci Drug Res. 2010;2(1):35–39.
   Google Scholar
• Pandit V, Khanum A, Bhaskaran S, et al. Formulation and evaluation of transdermal films for the treatment of overactive bladder. Int J Pharmtech Res. 2009;1(3):799–804.
   Google Scholar
• Mahajan NM, Zode GH, Mahapatra DK, et al. Formulation development and evaluation of transdermal patch of piroxicam for treating dysmenorrhea. J Appl Pharm Sci. 2018;8(11):035–041.
   Google Scholar
• Rajabalaya R. Studies on effect of plasticizer on invitro release and exvivo permeation from eudragit e100 based chlorpheniramine maleate matrix type transdermal delivery system. J Excipients Food Chem. 2010;1(2):3–12.
   Google Scholar
• Singh A, Bali A. Formulation and characterization of transdermal patches for controlled delivery of duloxetine hydrochloride. J Anal Sci Technol. 2016;7(1):25.
   Web of Science ®Google Scholar
• Bangale G, Rathinaraj BS, Rajesh K, et al. Design and evaluation of transdermal films of atenolol. J Chem Pharm Res. 2010;2(3):593–604.
   Google Scholar
• Simon A, Amaro MI, Healy AM, et al. Development of a discriminative in vitro release test for rivastigmine transdermal patches using pharmacopeial apparatuses: USP 5 and USP 6. AAPS PharmSciTech. 2017;18(7):2561–2569.
   PubMed Web of Science ®Google Scholar
• Suga M, Asahina S, Sakuda Y, et al. Recent progress in scanning electron microscopy for the characterization of fine structural details of nano materials. Prog Solid State Chem. 2014;42(1–2):1–21.
   Web of Science ®Google Scholar
• Banerjee S, Chattopadhyay P, Ghosh A, et al. Accelerated stability testing of a transdermal patch composed of eserine and pralidoxime chloride for prophylaxis against (±)-anatoxin A poisoning. J Food Drug Anal. 2014;22(2):264–270.
   Web of Science ®Google Scholar
• Vishnu Yamsani V, Kumar Mudulaghar M, Afreen S, et al. Formulation design and in vitro ex vivo evaluation of transdermal patches of cinnarizine. Pak J Pharm Sci. 2017;30(6):2075-2083.
   Web of Science ®Google Scholar
• Banerjee S, Chattopadhyay P, Ghosh A, et al. Pharmacokinetic and biodistribution study of eserine and pralidoxime chloride in rabbits following a single application of a transdermal patch. Eur J Drug Metab Pharmacokinet. 2016;41(3):219–230.
   PubMed Web of Science ®Google Scholar
• Chakraborty P, Parcha V, Chakraborty DD, et al. Comparative study on the predictability of statistical models (RSM and ANN) on the behavior of optimized buccoadhesive wafers containing Loratadine and their in vivo assessment. Drug Deliv. 2016;23(3):1016–1027.
   Web of Science ®Google Scholar
• Kováčik A, Kopečná M, Vávrová K. Permeation enhancers in transdermal drug delivery: benefits and limitations. Expert Opin Drug Deliv. 2020;17(2):145–155.
   PubMed Web of Science ®Google Scholar
• Bhattacharya SS, Banerjee S. Skin permeation of buflomedil form adhesive matrix patches. J Adhes Sci Technol. 2015;29(10):925–942.
   Web of Science ®Google Scholar
• Craig DQ. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int J Pharm. 2002;231(2):131–144.
   PubMed Web of Science ®Google Scholar
• Wagner KG, McGinity JW. Influence of chloride ion exchange on the permeability and drug release of Eudragit RS 30 D films. J Control Release. 2002;82(2–3):385–397.
   PubMed Web of Science ®Google Scholar
• Akhgari A, Tavakol A. Prediction of optimum combination of Eudragit RS/Eudragit RL/ethyl cellulose polymeric free films based on experimental design for using as a coating system for sustained release theophylline pellets. Adv Pharm Bull. 2016;6(2):219.
   PubMed Web of Science ®Google Scholar
• Bodmeier R, Guo X, Sarabia RE, et al. The influence of buffer species and strength on diltiazem HC1 release from beads coated with the aqueous cationic polymer dispersions, Eudragit RS, RL 30D. Pharm Res. 1996;13(1):52–56.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee SH, Lim EA, et al. Formulation optimization of solid dispersion of mosapride hydrochloride. Arch Pharm Res. 2011;34(9):1467.
   PubMed Web of Science ®Google Scholar
• Van den Mooter G, Wuyts M, Blaton N, et al. Physical stabilisation of amorphous ketoconazole in solid dispersions with polyvinylpyrrolidone K25. Eur J Pharm Sci. 2001;12(3):261–269.
   PubMed Web of Science ®Google Scholar
• Yi H-G, Choi Y-J, Kang KS, et al. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release. 2016;238:231–241.
   PubMed Web of Science ®Google Scholar
• Zhao J-H, Fu J-H, Wang S-M, et al. A novel transdermal patch incorporating isosorbide dinitrate with bisoprolol: in vitro and in vivo characterization. Int J Pharm. 2007;337(1–2):88–101.
   PubMed Web of Science ®Google Scholar
• Toutain P-L, Bousquet‐Mélou A. Plasma terminal half‐life. J Vet Pharmacol Ther. 2004;27(6):427–439.
   PubMed Web of Science ®Google Scholar